• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Conduit Pharmaceuticals Inc. - Common Stock (NQ: CDT )

    0.0881 -0.0029 (-3.19%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Conduit Pharmaceuticals Inc. - Common Stock

    Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes
    From Conduit Pharmaceuticals
    Via GlobeNewswire
    Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    From Conduit Pharmaceuticals
    Via GlobeNewswire
    Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
    From Conduit Pharmaceuticals
    Via GlobeNewswire
    Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
    From Conduit Pharmaceuticals
    Via GlobeNewswire
    Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
    Composition of matter patent approval underscores the Company’s solid-form technology to maximize future value and ability to strengthen and broaden its intellectual property portfolio 
    From Conduit Pharmaceuticals
    Via GlobeNewswire
    Conduit Pharmaceuticals to Join Russell 3000® Index
    From Conduit Pharmaceuticals
    Via GlobeNewswire
    A Presidio Property Trust Major Investment To Be Part of Russell 2000®
    From Presidio Property Trust, Inc.
    Via GlobeNewswire
    Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
    From Conduit Pharmaceuticals
    Via GlobeNewswire
    Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
    From Conduit Pharmaceuticals
    Via GlobeNewswire
    Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    From Conduit Pharmaceuticals
    Via GlobeNewswire
    Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
    From Conduit Pharmaceuticals
    Via GlobeNewswire
    Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
    Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed Phase I trials 
    From Conduit Pharmaceuticals
    Via GlobeNewswire
    Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW)
    From Presidio Property Trust, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.